Literature DB >> 14215184

RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.

H M MEYER, D D HOSTETLER, B C BERNHEIM, N G ROGERS, P LAMBIN, A CHASSARY, J E SMADEL.   

Abstract

Experience so far with the Enders B-level Edmonston strain of live attenuated measles vaccine has been principally with children in the USA in whom natural measles carries a low mortality. Measles is associated with an appreciably higher mortality rate in developing countries; in Upper Volta, climate, nutritional status, degree of parasitic infestation and concurrent infections may contribute to this. The present report summarizes a pilot study in Ouagadougou, Upper Volta, designed to obtain information on the response of Volta children to Enders vaccine and to determine the feasibility of using this vaccine on a large scale.The observations indicate that Volta children, despite the hazards of natural measles, respond in essentially the same manner to live vaccine given alone or with gamma-globulin as do children in other areas. The febrile reactions which characterize infection with the attenuated measles virus were of insufficient importance to warrant the concurrent use of gamma-globulin in a forthcoming mass measles vaccination campaign in Upper Volta.

Entities:  

Keywords:  AFRICA, CENTRAL; ANEMIA; CHILD; GAMMA GLOBULIN; INFANT; INFANT NUTRITION; MALARIA; MEASLES; MEASLES VACCINE; STATISTICS; VACCINATION

Mesh:

Substances:

Year:  1964        PMID: 14215184      PMCID: PMC2555080     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Importance of measles to India.

Authors:  P N TANEJA; O P GHAI; O N BHAKOO
Journal:  Am J Dis Child       Date:  1962-03

2.  Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions.

Authors:  J STOKES; R WEIBEL; R HALENDA; C M REILLY; M R HILLEMAN
Journal:  Am J Dis Child       Date:  1962-03

3.  Vaccination against measles. II. Clinical trial in Nigerian children.

Authors:  P COLLARD; R G HENDRICKSE; D MONTEFIORE; P SHERMAN; H M VAN DER WALL; D MORLEY; A P GOFFE; G D LAURENCE; T M POLLOCK
Journal:  Br Med J       Date:  1961-11-11

4.  Electroencephalography in natural and attenuated measles.

Authors:  F A GIBBS; I M ROSENTHAL
Journal:  Am J Dis Child       Date:  1962-03

5.  Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy.

Authors:  M R HILLEMAN; J STOKES; E B BUYNAK; R WEIBEL; R HALENDA; H GOLDNER
Journal:  Am J Dis Child       Date:  1962-03

6.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

7.  Use of Edmonston attenuated measles strain. A summary of three years' experience.

Authors:  S L KATZ; J F ENDERS; A HOLLOWAY
Journal:  Am J Dis Child       Date:  1962-03

8.  Medical importance of measles in Chile.

Authors:  C RISTORI; H BOCCARDO; J M BORGONO; R ARMIJO
Journal:  Am J Dis Child       Date:  1962-03

9.  Measles serologic standards.

Authors:  H M MEYER; B E BROOKS; R D DOUGLAS; N G ROGERS
Journal:  Am J Dis Child       Date:  1962-03

10.  Clinical and immunological studies on a live attenuated measles virus vaccine in infants and children.

Authors:  P HALONEN; P FORSSELL; H HALONEN; O PETTAY; R STENSTROM; S OHMAN; N OKER-BLOM
Journal:  Acta Paediatr       Date:  1962-07       Impact factor: 2.299

View more
  8 in total

1.  Smallpox eradication in West and Central Africa.

Authors:  W H Foege; J D Millar; D A Henderson
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization.

Authors: 
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

3.  Measles epidemiology and control in Western Nigeria.

Authors:  M E Grigsby; J I Adetosoye
Journal:  J Natl Med Assoc       Date:  1973-09       Impact factor: 1.798

4.  Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran.

Authors:  K Naficy; S Saidi; R Nategh; A Mostatab; E Akbarshahy
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Edmonston B and a further attenuated measles vaccine--a placebo controlled double blind comparison.

Authors:  G Miller; J Gale; V Villarejos; W James; C G Arteaga; H Casey; D A Henderson
Journal:  Am J Public Health Nations Health       Date:  1967-08

6.  Interventions for the control of diarrhoeal diseases among young children: measles immunization.

Authors:  R G Feachem; M A Koblinsky
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

7.  Lessons from the eradication of smallpox: an interview with D. A. Henderson.

Authors:  D A Henderson; Petra Klepac
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 8.  Mass vaccination and surveillance/containment in the eradication of smallpox.

Authors:  J M Lane
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.